The American Society of Hematology
Last Modified: May 22, 2014
Dates: October 17-18, 2014
Location: Baltimore, Maryland
Sponsoring Group: The American Society of Hematology
Web Page URL: www.hematology.org/sas_calendar
Topics Covered: Clinical updates in hematology with a focus on lymphoid malignancies.
Objectives: The ASH® State-of-the-Art Symposium (SAS) provides up-to-date, evidence-based continuing medical education that spans the medical field and practice of hematology. The smaller, clinically focused program format provides attendees with ample opportunities to discuss their actual patient cases and practice challenges with experts in the field.
Who Should Attend: Hematologists, Hematologist-Oncologists
Continuing Education: Yes
Dec 11, 2013 - Many patients with myeloproliferative neoplasms without mutations in the Janus kinase 2 gene (JAK2) or in the thrombopoietin receptor gene (MPL) have mutations in the CALR gene encoding calreticulin, according to two studies published online Dec. 10 in the New England Journal of Medicine. The research was published to coincide with presentation at the annual meeting of the American Society of Hematology, held from Dec. 7 to 10 in New Orleans.
Dec 14, 2011
Oct 20, 2014
Oct 20, 2014
Oct 3, 2014
Sep 3, 2014